Search form

 

Press Releases


Axcan Pharma to present at the Scotia Capital Pharmaceutical and Biotechnology Conference


Apr 19, 2006 - 11:59 ET

MONT-SAINT-HILAIRE, QC, April 19 - Axcan Pharma Inc.

("Axcan" or the "Company") today announced that on Wednesday, April 26th,
2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will
present an overview of the Company at the Scotia Capital Pharmaceutical &
Biotechnology Conference to be held in Toronto, ON. This presentation will
take place at 11:10 a.m. (Eastern time).

A webcast of Axcan's presentation will also be accessible via the
Company's website at www.axcan.com.

Axcan is a leading specialty pharmaceutical company involved in the field
of gastroenterology. The Company markets a broad line of prescription products
sold for the treatment of symptoms in a number of gastrointestinal diseases
and disorders such as inflammatory bowel disease, irritable bowel syndrome,
cholestatic liver diseases and complications related to cystic fibrosis.
Axcan's products are marketed by its own sales force in North America and
Europe. Its common shares are listed on the Toronto Stock Exchange under the
symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".



For further information: Isabelle Adjahi, Director, Investor Relations,
Axcan Pharma Inc., (450) 467-2600, ext. 2000, www.axcan.com; Source:
AXCAN PHARMA INC.